Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study.

[1]  A. Gastaldelli,et al.  Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD , 2017, Scientific Reports.

[2]  C. Medana,et al.  Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver. , 2017, The Journal of nutritional biochemistry.

[3]  A. Feldstein,et al.  Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis , 2017, PloS one.

[4]  C. Medana,et al.  Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice. , 2016, Free radical biology & medicine.

[5]  R. Bostick,et al.  Circulating Biomarkers of Gut Barrier Function: Correlates and Nonresponse to Calcium Supplementation among Colon Adenoma Patients , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[6]  M. Grechnikova.  Oxidative modification of LDL and antioxidant enzymes in diabetes mellitus and atherosclerosis , 2015 .

[7]  Ashley A. Martin,et al.  Energy-dense snacks can have the same expected satiation as sugar-containing beverages , 2015, Appetite.

[8]  C. Thiemermann,et al.  Targeting the NLRP3 inflammasome to Reduce Diet-induced Metabolic Abnormalities in Mice , 2015, Molecular medicine.

[9]  Frank B Hu,et al.  Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us. , 2015, Journal of the American College of Cardiology.

[10]  F. Fåk,et al.  Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. , 2015, Molecular nutrition & food research.

[11]  Chiara Cordero,et al.  Alignment for comprehensive two-dimensional gas chromatography with dual secondary columns and detectors. , 2015, Analytical chemistry.

[12]  R. Ferraris,et al.  Transport, metabolism, and endosomal trafficking‐dependent regulation of intestinal fructose absorption , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  L. Cigliano,et al.  Rescue of Fructose-Induced Metabolic Syndrome by Antibiotics or Faecal Transplantation in a Rat Model of Obesity , 2015, PloS one.

[14]  J. Krepinsky,et al.  SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis. , 2015, Journal of the American Society of Nephrology : JASN.

[15]  G. Favero,et al.  Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet , 2015, PloS one.

[16]  M. Schambelan,et al.  Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. , 2015, The Journal of clinical endocrinology and metabolism.

[17]  M. Conlon,et al.  The Impact of Diet and Lifestyle on Gut Microbiota and Human Health , 2014, Nutrients.

[18]  R. Naftalin.  Does apical membrane GLUT2 have a role in intestinal glucose uptake? , 2014, F1000Research.

[19]  H. Tilg,et al.  Intestinal permeability – a new target for disease prevention and therapy , 2014, BMC Gastroenterology.

[20]  Mehrbod Estaki,et al.  Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity. , 2014, World journal of gastroenterology.

[21]  J. D'haese,et al.  Effect of High Sugar Intake on Glucose Transporter and Weight Regulating Hormones in Mice and Humans , 2014, PloS one.

[22]  I. Seiquer,et al.  Maillard reaction products modulate gut microbiota composition in adolescents. , 2014, Molecular nutrition & food research.

[23]  I. Sadowska-Bartosz,et al.  Kinetics of Glycoxidation of Bovine Serum Albumin by Methylglyoxal and Glyoxal and its Prevention by Various Compounds , 2014, Molecules.

[24]  T. Mehta,et al.  Impact of Targeted Specific Antibiotic Delivery for Gut Microbiota Modulation on High-Fructose-Fed Rats , 2014, Applied Biochemistry and Biotechnology.

[25]  H. Flint,et al.  Phylogenetic distribution of three pathways for propionate production within the human gut microbiota , 2014, The ISME Journal.

[26]  E. Elinav,et al.  Inflammasomes and metabolic disease. , 2014, Annual review of physiology.

[27]  Philip R. Cohen,et al.  IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation , 2013, Proceedings of the National Academy of Sciences.

[28]  C. Mandarim-de-Lacerda,et al.  Hepatic Adverse Effects of Fructose Consumption Independent of Overweight/Obesity , 2013, International journal of molecular sciences.

[29]  P. Pevzner,et al.  Assembling Single-Cell Genomes and Mini-Metagenomes From Chimeric MDA Products , 2013, J. Comput. Biol..

[30]  C. Medana,et al.  Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[31]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[32]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[33]  R. Ferraris,et al.  The role of fructose transporters in diseases linked to excessive fructose intake , 2013, The Journal of physiology.

[34]  C. Chassard,et al.  Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host–microbe interactions contributing to obesity , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[35]  P. Holt,et al.  A high-fat diet is associated with endotoxemia that originates from the gut. , 2012, Gastroenterology.

[36]  E. Birkmann,et al.  Kinetics of advanced glycation end products formation on bovine serum albumin with various reducing sugars and dicarbonyl compounds in equimolar ratios. , 2012, Rejuvenation research.

[37]  R. Alfenas,et al.  Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia , 2012, British Journal of Nutrition.

[38]  H. Parker,et al.  Na+-d-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion , 2011, Diabetes.

[39]  C. Graaf.  Trustworthy satiety claims are good for science and society. Comment on ‘Satiety. No way to slim’ , 2011, Appetite.

[40]  J. Nicholson,et al.  Global urinary metabolic profiling procedures using gas chromatography–mass spectrometry , 2011, Nature Protocols.

[41]  K. Clément,et al.  GLUT2 Accumulation in Enterocyte Apical and Intracellular Membranes , 2011, Diabetes.

[42]  M. Sarr,et al.  Acute Enterocyte Adaptation to Luminal Glucose: A Posttranslational Mechanism for Rapid Apical Recruitment of the Transporter GLUT2 , 2011, Journal of Gastrointestinal Surgery.

[43]  S. Rizkalla.  Health implications of fructose consumption: A review of recent data , 2010, Nutrition & metabolism.

[44]  R. Guigó,et al.  Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. , 2010, Genome research.

[45]  C. Thiemermann,et al.  Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation , 2010, British journal of pharmacology.

[46]  N. Wiernsperger,et al.  Possible Links between Intestinal Permeablity and Food Processing: A Potential Therapeutic Niche for Glutamine , 2010, Clinics.

[47]  J. Schwarz,et al.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome , 2010, Nature Reviews Gastroenterology &Hepatology.

[48]  A. Moran,et al.  Expression of Na+/glucose co-transporter 1 (SGLT1) in the intestine of piglets weaned to different concentrations of dietary carbohydrate , 2010, British Journal of Nutrition.

[49]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[50]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[51]  Manabu T. Nakamura,et al.  Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus. , 2009, Biochemical and biophysical research communications.

[52]  N. Cole,et al.  National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. , 2009, The Journal of nutrition.

[53]  R. Kreis,et al.  Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. , 2009, The American journal of clinical nutrition.

[54]  R. Townsend,et al.  Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. , 2009, The Journal of clinical endocrinology and metabolism.

[55]  Wei Zhang,et al.  Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. , 2009, The Journal of clinical investigation.

[56]  R. Ferraris,et al.  Regulation of the fructose transporter GLUT5 in health and disease. , 2008, American journal of physiology. Endocrinology and metabolism.

[57]  A. Leturque,et al.  Sugar absorption in the intestine: the role of GLUT2. , 2008, Annual review of nutrition.

[58]  M. le Gall,et al.  Sugar sensing by enterocytes combines polarity, membrane bound detectors and sugar metabolism , 2007, Journal of cellular physiology.

[59]  C. Cheeseman,et al.  Facilitated hexose transporters: new perspectives on form and function. , 2007, Physiology.

[60]  G. Gibson,et al.  Metabolism of Maillard reaction products by the human gut microbiota--implications for health. , 2006, Molecular nutrition & food research.

[61]  D. Meijer,et al.  On the role and fate of LPS-dephosphorylating activity in the rat liver. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[62]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[63]  C. Schalkwijk,et al.  Fructose‐mediated non‐enzymatic glycation: sweet coupling or bad modification , 2004, Diabetes/metabolism research and reviews.

[64]  W. Seinen,et al.  Calf Intestinal Alkaline Phosphatase, a Novel Therapeutic Drug for Lipopolysaccharide (LPS)-Mediated Diseases, Attenuates LPS Toxicity in Mice and Piglets , 2003, Journal of Pharmacology and Experimental Therapeutics.

[65]  A. Sclafani,et al.  High dietary fat promotes syndrome X in nonobese rats. , 2003, The Journal of nutrition.

[66]  D. Bessesen.  The role of carbohydrates in insulin resistance. , 2001, The Journal of nutrition.

[67]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[68]  Russ B. Altman,et al.  Genome Analysis , 2011, Bioinform..